Manufacturers of anti-TB drugs invited to submit expressions of interest
26 July 2011 - Geneva - The Stop TB Partnership's Global Drug Facility (GDF) and the Global Fund invite manufacturers of first, second and third line anti-tuberculosis (TB) drugs to submit expressions of interest for product evaluation by an expert review panel.
Manufacturers should submit dossiers for products not WHO-Prequalified and/or SRA-authorized. The deadline for drug product dossier submissions is 15 September 2011.
In This Section
News editor:
Judith Mandelbaum-Schmid
News writers:
Sam Nuttall
Vittorio Cammarota
Young-Ae Chu
Jenniffer Dietrich
Elisabetta Minelli